Acknowledgement
This research was supported by grants from the National Research Foundation of Korea (NRF) (NRF-2022R1C1C2011617 to H.-K.J) and by Korean Fund for Regenerative Medicine funded by Ministry of Science and ICT, Ministry of Health and Welfare (RS-2022-00070316 to H.-J.C), Republic of Korea, and Seoul National University Research Grant.
References
- Merkle FT, Eggan K. Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell 2013;12:656-668 https://doi.org/10.1016/j.stem.2013.05.016
- Musunuru K. Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis Model Mech 2013;6:896-904 https://doi.org/10.1242/dmm.012054
- Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell 2020;27:523-531 https://doi.org/10.1016/j.stem.2020.09.014
- Rowe RG, Daley GQ. Induced pluripotent stem cells in disease modelling and drug discovery. Nat Rev Genet 2019;20:377-388 https://doi.org/10.1038/s41576-019-0100-z
- Anzalone AV, Koblan LW, Liu DR. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol 2020;38:824-844 https://doi.org/10.1038/s41587-020-0561-9
- Jeong YK, Song B, Bae S. Current status and challenges of DNA base editing tools. Mol Ther 2020;28:1938-1952 https://doi.org/10.1016/j.ymthe.2020.07.021
- Park JC, Kim J, Jang HK, Lee SY, Kim KT, Kwon EJ, Park S, Lee HS, Choi H, Park SY, Choi HJ, Park SJ, Moon SH, Bae S, Cha HJ. Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors. Biomaterials 2022;282:121419
- Kim KT, Park JC, Jang HK, Lee H, Park S, Kim J, Kwon OS, Go YH, Jin Y, Kim W, Lee J, Bae S, Cha HJ. Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance. Biomaterials 2020;262:120295
- Chemello F, Chai AC, Li H, Rodriguez-Caycedo C, Sanchez-Ortiz E, Atmanli A, Mireault AA, Liu N, Bassel-Duby R, Olson EN. Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing. Sci Adv 2021;7:eabg4910
- Martin RM, Ikeda K, Cromer MK, Uchida N, Nishimura T, Romano R, Tong AJ, Lemgart VT, Camarena J, Pavel-Dinu M, Sindhu C, Wiebking V, Vaidyanathan S, Dever DP, Bak RO, Laustsen A, Lesch BJ, Jakobsen MR, Sebastiano V, Nakauchi H, Porteus MH. Highly efficient and marker-free genome editing of human pluripotent stem cells by CRISPR-Cas9 RNP and AAV6 donor-mediated homologous recombination. Cell Stem Cell 2019;24:821-828.e5 https://doi.org/10.1016/j.stem.2019.04.001
- Yu C, Liu Y, Ma T, Liu K, Xu S, Zhang Y, Liu H, La Russa M, Xie M, Ding S, Qi LS. Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell 2015;16:142-147 https://doi.org/10.1016/j.stem.2015.01.003
- Li S, Akrap N, Cerboni S, Porritt MJ, Wimberger S, Lundin A, Moller C, Firth M, Gordon E, Lazovic B, Sienska A, Pane LS, Coelho MA, Ciotta G, Pellegrini G, Sini M, Xu X, Mitra S, Bohlooly-Y M, Taylor BJM, Sienski G, Maresca M. Universal toxin-based selection for precise genome engineering in human cells. Nat Commun 2021;12:497 Erratum in: Nat Commun 2021;12:2832
- Ihry RJ, Worringer KA, Salick MR, Frias E, Ho D, Theriault K, Kommineni S, Chen J, Sondey M, Ye C, Randhawa R, Kulkarni T, Yang Z, McAllister G, Russ C, Reece-Hoyes J, Forrester W, Hoffman GR, Dolmetsch R, Kaykas A. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med 2018;24:939-946 https://doi.org/10.1038/s41591-018-0050-6
- Simkin D, Papakis V, Bustos BI, Ambrosi CM, Ryan SJ, Baru V, Williams LA, Dempsey GT, McManus OB, Landers JE, Lubbe SJ, George AL Jr, Kiskinis E. Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls. Stem Cell Reports 2022;17:993-1008 https://doi.org/10.1016/j.stemcr.2022.02.008
- Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 2016;533:420-424 https://doi.org/10.1038/nature17946
- Eid A, Alshareef S, Mahfouz MM. CRISPR base editors: genome editing without double-stranded breaks. Biochem J 2018;475:1955-1964 https://doi.org/10.1042/BCJ20170793
- Osborn MJ, Newby GA, McElroy AN, Knipping F, Nielsen SC, Riddle MJ, Xia L, Chen W, Eide CR, Webber BR, Wandall HH, Dabelsteen S, Blazar BR, Liu DR, Tolar J. Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs. J Invest Dermatol 2020;140:338-347.e5 https://doi.org/10.1016/j.jid.2019.07.701
- Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ, Wilson C, Newby GA, Raguram A, Liu DR. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 2019;576:149-157 https://doi.org/10.1038/s41586-019-1711-4
- Rees HA, Liu DR. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet 2018;19:770-788 Erratum in: Nat Rev Genet 2018;19:801
- Richter MF, Zhao KT, Eton E, Lapinaite A, Newby GA, Thuronyi BW, Wilson C, Koblan LW, Zeng J, Bauer DE, Doudna JA, Liu DR. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat Biotechnol 2020;38:883-891 Erratum in: Nat Biotechnol 2020;38:901
- Koblan LW, Doman JL, Wilson C, Levy JM, Tay T, Newby GA, Maianti JP, Raguram A, Liu DR. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol 2018;36:843-846 https://doi.org/10.1038/nbt.4172
- Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR. Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage. Nature 2017;551:464-471 Erratum in: Nature 2018;559:E8
- Duncan BK, Miller JH. Mutagenic deamination of cytosine residues in DNA. Nature 1980;287:560-561 https://doi.org/10.1038/287560a0
- Komor AC, Zhao KT, Packer MS, Gaudelli NM, Waterbury AL, Koblan LW, Kim YB, Badran AH, Liu DR. Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. Sci Adv 2017;3:eaao4774
- Park JC, Jang HK, Kim J, Han JH, Jung Y, Kim K, Bae S, Cha HJ. High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells. Mol Ther Nucleic Acids 2021;27:175-183 https://doi.org/10.1016/j.omtn.2021.11.023
- Doman JL, Raguram A, Newby GA, Liu DR. Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat Biotechnol 2020;38:620-628 https://doi.org/10.1038/s41587-020-0414-6
- Huang TP, Zhao KT, Miller SM, Gaudelli NM, Oakes BL, Fellmann C, Savage DF, Liu DR. Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors. Nat Biotechnol 2019;37:626-631 Erratum in: Nat Biotechnol 2019;37:820
- Thuronyi BW, Koblan LW, Levy JM, Yeh WH, Zheng C, Newby GA, Wilson C, Bhaumik M, Shubina-Oleinik O, Holt JR, Liu DR. Continuous evolution of base editors with expanded target compatibility and improved activity. Nat Biotechnol 2019;37:1070-1079 Erratum in: Nat Biotechnol 2019;37:1091 https://doi.org/10.1038/s41587-019-0193-0
- Kim YB, Komor AC, Levy JM, Packer MS, Zhao KT, Liu DR. Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat Biotechnol 2017;35:371-376 https://doi.org/10.1038/nbt.3803
- Song M, Kim HK, Lee S, Kim Y, Seo SY, Park J, Choi JW, Jang H, Shin JH, Min S, Quan Z, Kim JH, Kang HC, Yoon S, Kim HH. Sequence-specific prediction of the efficiencies of adenine and cytosine base editors. Nat Biotechnol 2020;38:1037-1043 https://doi.org/10.1038/s41587-020-0573-5
- Habib O, Habib G, Hwang GH, Bae S. Comprehensive analysis of prime editing outcomes in human embryonic stem cells. Nucleic Acids Res 2022;50:1187-1197 https://doi.org/10.1093/nar/gkab1295